Volume 5, Issue 4, Page 8 (April 2009)
10 of 35
PREVIEW
FULL TEXT
FULL-TEXT PDF (79 KB)
CITATION ALERT
CITED BY
RELATED ARTICLES
EXPORT CITATION
EMAIL TO A COLLEAGUE
RIGHTS/PERMISSIONS
NEED REPRINTS?
BOOKMARK ARTICLE
The FDA advisory is at www.fda.gov/cder/drug/advisory/efalizumab.htm
PII: S1553-3212(09)70081-0
doi:10.1016/S1553-3212(09)70081-0
© 2009 Elsevier Inc. All rights reserved.
Copyright © 2012 Elsevier Inc. All rights reserved. | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.
PREVIEW